PUBLISHER: The Business Research Company | PRODUCT CODE: 1804216
PUBLISHER: The Business Research Company | PRODUCT CODE: 1804216
Bioengineering technology involves applying principles and techniques from engineering and the natural sciences to develop technologies and solutions for understanding, manipulating, and utilizing biological systems, particularly in the fields of medicine, biology, and healthcare.
The primary types of products in bioengineering technology include biomedical engineering, genetic engineering, biotechnology, tissue engineering, biomechanics engineering, biomaterials, nano-biotechnology, bioinformatics, and others. Biomedical engineering entails applying engineering principles and design concepts to medicine and biology for healthcare purposes. It encompasses various technologies such as nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, and fermentation, and finds applications in health, food and agriculture, natural resources, and the environment.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and emerging trade disputes in spring 2025 are having a profound impact on the agriculture sector by driving up the costs of essential inputs such as seeds, fertilizers, and machinery components sourced from international markets. Higher duties on imported agrochemicals and farm equipment have substantially increased operational expenses for farmers. At the same time, retaliatory tariffs from key global buyers have reduced demand for major U.S. agricultural exports, including corn, wheat, and dairy, straining farm incomes. In response, many producers are exploring crop diversification, investing in precision agriculture to optimize resource use, and calling for government support through subsidies and improved trade access.
The bioengineering technology market research report is one of a series of new reports from The Business Research Company that provides bioengineering technology market statistics, including bioengineering technology industry global market size, regional shares, competitors with a bioengineering technology market share, detailed bioengineering technology market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineering technology industry. This bioengineering technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioengineering technology market size has grown rapidly in recent years. It will grow from $320.38 billion in 2024 to $363.01 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing aging population, increasing prevalence of chronic diseases, bioengineering technology market growth, favorable government initiatives, growing genetic engineering strategies.
The bioengineering technology market size is expected to see rapid growth in the next few years. It will grow to $593.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increased focus on cell therapies, rapid growth of synthetic biology, precision medicine advancements, increasing application in agriculture, expanded use in environmental solutions. Major trends in the forecast period include advanced gene editing techniques, convergence of technologies, advancements in precision medicine, global collaboration and partnership, synthetic biology applications.
The forecast of 13.1% growth over the next five years indicates a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. This may have a direct effect on the US by interrupting the flow of gene-editing tools and laboratory equipment from Switzerland and Singapore, which could lead to delayed crop innovation. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of chronic diseases is expected to drive the growth of the bioengineering technology market in the coming years. Chronic diseases are long-term health conditions marked by their persistent and ongoing nature. Bioengineering technology plays a crucial role in managing and treating these diseases, offering innovative solutions that improve patient outcomes and enhance quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the age-standardized death rate associated with chronic conditions was 448 per 100,000 population, increasing slightly to 459 per 100,000 in 2021, and rising further to 490 per 100,000 in 2022. As a result, the growing prevalence of chronic diseases is contributing to the expansion of the bioengineering technology market.
Key players in the bioengineering technology market are focusing on developing innovative technological products, such as Mito Plus, to advance the field of regenerative medicine. Mito Plus is a cutting-edge 3D bioprinter designed to produce tissues or organs resembling natural body parts, containing living cells, using 3D printing technology. For example, Avay Biosciences Pvt. Ltd., an India-based manufacturer and service provider of 3D printers, introduced Mito Plus in November 2022. This state-of-the-art bioprinter is hailed as one of the most advanced in its price range, capable of printing a wide range of biomaterials and featuring built-in UV curing options. It also incorporates HEPA filters and temperature control, enabling cooling of the printhead and print bed by up to 4 degrees Celsius, as well as heating capabilities.
In March 2023, Ginkgo Bioworks, a US-based horizontal platform for cell programming, acquired FGen AG for an undisclosed sum. This acquisition strengthens Ginkgo's position as a leader in the bioengineering field, providing it with a robust tool for strain development and optimization across various industries. FGen AG is a Switzerland-based bioengineering company.
Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton Dickinson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc., Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics
North America was the largest region in the bioengineering technology market in 2024. The regions covered in the bioengineering technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioengineering technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bioengineering technology market includes revenues earned by entities service such as medical diagnostic services, pharmaceutical services, personalized medicine services, engineering, and nanotechnology in medicine services, biological data analysis services, regenerative medicine services, and health information technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The bioengineering technology market consists of sales of implantable medical devices, wearable health monitoring devices, biomedical imaging equipment, and diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioengineering Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioengineering technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioengineering technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioengineering technology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.